These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010. Liu JW; Ko WC; Huang CH; Liao CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Chen YH; Lu PL; Sun W; Wang LS; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR Antimicrob Agents Chemother; 2012 Mar; 56(3):1414-7. PubMed ID: 22155819 [TBL] [Abstract][Full Text] [Related]
6. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae. Ballestero-Téllez M; Docobo-Pérez F; Rodríguez-Martínez JM; Conejo MC; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A Clin Microbiol Infect; 2017 May; 23(5):325-331. PubMed ID: 28062317 [TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates. López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012. Walkty A; Adam H; Baxter M; Denisuik A; Lagacé-Wiens P; Karlowsky JA; Hoban DJ; Zhanel GG Antimicrob Agents Chemother; 2014 May; 58(5):2554-63. PubMed ID: 24550325 [TBL] [Abstract][Full Text] [Related]
9. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species. Haidar G; Alkroud A; Cheng S; Churilla TM; Churilla BM; Shields RK; Doi Y; Clancy CJ; Nguyen MH Antimicrob Agents Chemother; 2016 Sep; 60(9):5208-14. PubMed ID: 27297487 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers. Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516 [TBL] [Abstract][Full Text] [Related]
11. ARGONAUT II Study of the Jacobs MR; Good CE; Hujer AM; Abdelhamed AM; Rhoads DD; Hujer KM; Rudin SD; Domitrovic TN; Connolly LE; Krause KM; Patel R; Arias CA; Kreiswirth BN; Rojas LJ; D'Souza R; White RC; Brinkac LM; Nguyen K; Singh I; Fouts DE; van Duin D; Bonomo RA; Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152078 [TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro activities of plazomicin and other aminoglycosides against clinical isolates of Klebsiella pneumoniae and Escherichia coli. İnce G; Mirza HC; Üsküdar Güçlü A; Gümüş H; Erol Ç; Başustaoğlu A J Antimicrob Chemother; 2021 Nov; 76(12):3192-3196. PubMed ID: 34499728 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE). Zhang Y; Kashikar A; Bush K J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224 [TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection. Noel AR; Attwood M; Bowker KE; Kim A; Krause KM; MacGowan AP Int J Antimicrob Agents; 2019 Nov; 54(5):626-632. PubMed ID: 31299297 [TBL] [Abstract][Full Text] [Related]
15. Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla Johnston BD; Thuras P; Porter SB; Clabots C; Johnson JR Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2069-2075. PubMed ID: 33893571 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019. Jean SS; Ko WC; Hsueh PR; Int J Antimicrob Agents; 2020 Jul; 56(1):106016. PubMed ID: 32422316 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974 [TBL] [Abstract][Full Text] [Related]
18. Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region. Johnston BD; Thuras P; Porter SB; Anacker M; VonBank B; Snippes Vagnone P; Witwer M; Castanheira M; Johnson JR J Antimicrob Chemother; 2021 Jul; 76(8):2061-2070. PubMed ID: 34097032 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains. Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381 [TBL] [Abstract][Full Text] [Related]
20. Expected plazomicin susceptibility in India based on the prevailing aminoglycoside resistance mechanisms in Gram-negative organisms derived from whole-genome sequencing. Pragasam AK; Jennifer SL; Solaimalai D; Muthuirulandi Sethuvel DP; Rachel T; Elangovan D; Vasudevan K; Gunasekaran K; Veeraraghavan B Indian J Med Microbiol; 2020; 38(3 & 4):313-318. PubMed ID: 33154241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]